Sunday, 24 February 2019

Aceto Corporation: Buy Low For The Bankruptcy Bounce II Update

On Wednesday we wrote about Pernix Therapeutics Holdings, Inc. (PTX) and how it was an ideal candidate for a bounce after getting hammered since announcing Chapter 11 bankruptcy. The result was a positive one as on Thursday it rose 34% to $0.39 before dropping to $0.32 on Friday. Aceto Corporation (ACET) is another stock that has been hammered down thanks to a Chapter 11 filing. It has dropped from $1.03 to $0.26 in three days, dropping again on Friday due to a NASDAQ delisting notice. The company plans to request a hearing before the March 4th deadline date, so the delisting threat should be put on hold for the time being. ACET was a top short pick from last year in our article "Short Aceto As It Heads Into Bankruptcy" and has dropped 90% since. Now that bankruptcy has officially gotten started, we believe it is a good time to cover any short and go long in order to play the bankruptcy bounce.

Why buy a stock that is going through bankruptcy? Because the recent trend has shown that companies that tank heavily after announcing bankruptcy recover soon thereafter. PG&E Corporation (PCG) tanked from over $40 to $7 over the past four months but has recovered to trade above $19 since filing for bankruptcy, filling a gap in its chart created on January 14. On the opposite end of the market cap spectrum, EnSync, Inc. (ESNC) shot up 47% to $0.13 on Wednesday and got close to filling the gap created by its threat of bankruptcy announcement on February 12. ACET has the potential to do what these two stocks and PTX have done over the next few days, especially since the Chapter 11 bankruptcy does not mean that the company is done. We are up to 808 followers despite not giving out a lot of alerts, a fact that we think is indicative of a successful, diligent and prudent stock picking history. If you like our picks you can follow our blog by clicking the follow button on the top of the left hand panel. You can also follow us on Twitter @StockTradePicks. We have over 3,600 followers on Twitter as well.

ACET dropped after announcing the following:

PORT WASHINGTON, N.Y., Feb. 19, 2019 (GLOBE NEWSWIRE) -- ACETO Corporation (ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, announced today that it has entered into a “stalking-horse” asset purchase agreement with an affiliate of New Mountain Capital, a leading growth-oriented investment firm with over $20 billion in assets under management, to sell its chemicals business assets for gross proceeds of $338 million in cash, plus the assumption of certain liabilities and subject to certain adjustments, on a cash-free and debt-free basis.

The sale will be conducted under Section 363 of the U.S. Bankruptcy Code. To facilitate the sale and satisfy its debt obligations, Aceto and its U.S. subsidiaries have filed voluntary petitions under Chapter 11 of the U.S. Bankruptcy Code in the U.S. Bankruptcy Court for the District of New Jersey (Newark). Aceto’s foreign chemicals business subsidiaries are not included in the filing but will be included in the sale. In addition, Aceto intends to enter into a stalking horse agreement for its subsidiary, Rising Pharmaceuticals. Aceto expects to complete the dispositions of its chemicals and Rising businesses before its fiscal year end on June 30, 2019.
“For the past several months, the Board has been conducting a comprehensive evaluation of strategic alternatives to address the Company’s debt burden in consultation with its financial and legal advisors while continuing to work cooperatively with its lenders.  After assessing its options, the Board has determined that Court-supervised sales of Aceto’s chemicals business assets and its subsidiary Rising Pharmaceuticals are in the best interest of the Company and its stakeholders,” said William C. Kennally III, Chief Executive Officer of Aceto. “This decision provides stability and deep capital resources to the Company and, importantly, ensures the continuity of customer, partner and supplier relationships critical to the Company’s businesses operations and success.” 

Aceto will operate its business in the ordinary course while it completes the sales of its chemicals business assets and its subsidiary Rising Pharmaceuticals.   To that end, Aceto has received a commitment for debtor-in-possession (DIP) financing of $60 million from a syndicate of lenders led by Wells Fargo Bank, N.A. The DIP financing will finance Aceto’s working capital needs through the completion of the sales transactions and support payments to vendors and suppliers for post-petition purchases in the ordinary course.

The proposed sales will be conducted through Court-supervised processes under Section 363 of the Bankruptcy Code, subject to Court-approved bidding procedures, potential receipt of higher and better offers at auction and approval by the Court.  PJT Partners LP is acting as Aceto’s financial advisor and investment banker to lead the sales processes under the bid procedures and Lowenstein Sandler LLP is serving as legal advisor. AP Services, an affiliate of AlixPartners LLP, is also serving as Chief Financial Officer and advisor to the Company. 
The bid for the chemicals business is $338 million, while no bid has been announced on its Rising Pharmaceuticals subsidiary yet. This "stalking horse bid", just like PTX's, is a minimum bid like what you see on an eBay auction. This bidding process will last for at least four months so there is lots of time to hear more bids. ACET's total liabilities are $702 million so it is not unfathomable to think that the total combined bids for both divisions could exceed that amount if things go well. ACET's total market cap is only $9 million. This is a very low valuation to bet that the bids will increase substantially from here. We think market participants will feel the same way and the stock price will have a substantial dead cat bounce like PTX, PCG or ESNC. Any stock has risk to it, especially one that is in bankruptcy proceedings so investors should trade accordingly.

Just like PTX, ACET has accumulated a lot of deferred tax assets from years of operating losses. ACET has accumulated $82 million in deferred tax assets which currently all but $5 million is offset by a valuation allowance. If ACET was to sell all of its operating assets and exist as a shell, that shell's tax assets have value in the instance of a reverse takeover that is done in a way to not invalidate them. This article gives a good overview of this process.

Disclosure: We are long ACET

2019 got off to a reasonable start in January for microcap stocks as the market in general was bullish for the month. There were a lot of stocks that spiked 100-500% in a matter of one or a few days. As we look towards the rest of 2019, we have to figure out what's next for microcap stocks? TradeMiner identifies seasonal trends and market cycles, the Penny Stock Prophet and Microcap Millionaires finds the next big small cap plays in various industries while Addicted to Profits makes trades from a Canadian perspective.

There are also some good books available on microcap stocks and day trading such as:

Mastering Microcaps: Strategies, Trends, and Stock Selection (Bloomberg Professional Library)

The Little Black Book of Microcap Investing: Beat the Market with NASDAQ/AMEX Microcap Stocks, OTCBB Penny Stocks, and Pink Sheet Stocks

Microcap Magic: Why The Biggest Returns Are In Stocks You've Never Heard Of

How to Day Trade for a Living: A Beginner’s Guide to Trading Tools and Tactics, Money Management, Discipline and Trading Psychology

How to Day Trade: A Detailed Guide to Day Trading Strategies, Risk Management, and Trader Psychology

A Beginner's Guide to Day Trading Online (2nd edition)

Stock Investing for Beginners: Marijuana Stocks


Here are some other good stock market resources. This includes technical analysis and day trading, dividend stock investing, gold and commodities, sector rotation, options trading and microcap trading strategies:

The dividend stock report from dividendstocksonline.com

No comments:

Post a Comment